He began his career in the pharmaceutical industry in 1996 when he joined Merck, Sharp & Dohme (MSD) at the UK subsidiary, advancing through different roles in the business around the world.

EVX-01 is designed with Evaxion’s AI-Immunology™ platform and tailored to target the unique tumor profile and immune ...

Research presented at SABCS 2024 provided new insights that may influence the management of early and advanced breast cancer.

The decision is a major win for MSD, which will now have the upper hand on BMS and its rival treatment Opdivo, which has been put forward for restricted use through the new Cancer Drugs Fund (CDF ...

A study published in Nature Medicine looks at the health risks and benefits linked to GLP-1 receptor agonists. Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University ...

Get access to the most accurate data and news on the aviation industry. We offer a comprehensive aviation industry database utilised by various entities such as operators, airports, FBO's, charter ...

We would like to personalise your experience with ch-aviation. Could you please tell us a bit more about yourself? We offer a comprehensive aviation industry database utilised by various entities such ...

Vaccination against COVID-19 reduces the incidence of hospitalization or death and the development of severe disease among ...

Eli Lilly and Merck & Co. are partnering with Purdue University to launch the Young Institute Pharmaceutical Manufacturing ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

Discover why Merck presents a compelling long-term investment opportunity with its discounted valuation, robust pipeline, and ...